Skip to main content

Table 3 Sample size determination for endotoxin

From: Effects of probiotics in patients with diabetes mellitus type 2: study protocol for a randomized, double-blind, placebo-controlled trial

Endotoxin baseline (U/L)

Difference in Δ-value (probiotics –placebo)

SD for change (common for both treatments)

Correlation for 1 and 2 measurements

Sample size (total) 2-tailed α: 0.05 Power: 80%

Sample size (total) 2-tailed α: 0.05 Power: 90%

10 (± 6)

−2

5.34

0.60

224

298

 

−2

5.04

0.65

200

266

 

−2

4.68

0.70

176

236

 

−2

4.26

0.75

148

198

 

−2

3.78

0.80

116

154

 

−2.5

5.34

0.60

144

192

 

−2.5

5.04

0.65

128

172

 

−2.5

4.68

0.70

114

152

 

−2.5

4.26

0.75

96

128

 

−2.5

3.78

0.80

76

100

 

−3

5.34

0.60

100

134

 

−3

5.04

0.65

90

120

 

−3

4.68

0.70

80

106

 

−3

4.26

0.75

68

90

 

−3

3.78

0.80

54

70

 

−4

5.34

0.60

58

76

 

−4

5.04

0.65

52

68

 

−4

4.68

0.70

46

62

 

−4

4.26

0.75

40

52

 

−4

3.78

0.80

32

40

  1. Δ-value, mean change; SD, standard deviation.